Discovery Proceeding in Zantac Cancer Litigation

Thousands of potential Zantac cancer plaintiffs eagerly await the first trial that will serve as a bellwether

Tuesday, October 20, 2020 - Sanofi, the maker of popular heartburn rug Zantac, is being accused of failing to warn consumers of the dangers of using their heartburn drug. Individual lawsuits have been consolidated in multi-district litigation in the Southern District of Florida overseen by Judge Robin L. Rosenberg. Rosenberg's first directive was to impanel 26 plaintiff attorneys that represent individual plaintiffs in the aggregate. The panel is comprised of a diversified group of men and women, young and old, experienced and new. The judge wanted the makeup of the panel to reflect the diversity of the 300 or so plaintiffs represented by them. Attorneys were required to submit completed census forms for their clients of "all filed and unfiled claims" by July 21, according to New York Legal Examiner.

MDL is different than a class action lawsuit as each case stands on its merit. Scientific testimony, administrative procedures, and discovery are streamlined by MDL to avoid repetition and waste valuable court time. Discovery is underway and attorneys are interrogating experts, requesting documents, and deposing witnesses. Lawyers have until January 2021 to obtain and submit their client's medical records. MDL discovery can take up to 18 months to complete and experts think that the case may not conclude until 2025 if no settlement is reached before then. Zantac cancer lawsuit attorneys have vast experience litigating against big corporations and pharmaceutical companies with a winning track record and offer a free consultation with no obligation to file a claim.

In the meantime, government health agencies like the FDA and Canada's Health Ministry are studying ranitidine to try and pinpoint the exact reason why NDMA levels skyrocketed from a safe 96 nanograms per capsule, into the millions as recorded by online testing pharmacy Valisure. It could take years for a definitive decision. In the meantime, procedures have been put in place in Canada to require companies that want to sell ranitidine to adhere to a strict and ongoing testing schedule, a model that could serve as a blueprint for Zantac and other antacids returning to the US market in the future.

Zantac was the world's leading heartburn and acid reflux medicine, treating upwards of 15 million Americans per year until the product was recalled by the US Food and Drug Administration (FDA). Online testing pharmacy Valisure found highly elevated levels of N-nitrosodimethylamine (NDMA), a known carcinogen, in Zantac tablets. Blood pressure medications and diabetes drugs have also been tested and proven to contain an unsafe level of the compound. Recalls are underway in all of North America for metformin, the leading medicine to treat type-2 diabetes.

Plaintiffs have filed suit claiming the regular and repeated use of Zantac has caused a wide variety of cancer. Lawyers are listening to potential plaintiffs that have developed stomach, liver, bladder, colorectal, prostate, esophageal, kidney, pancreatic, and breast cancer and also many others. Sanofi is accused of failing to warn their customers of what they knew or had an obligation to know about NDMA increasing when exposed to high temperatures, changes in humidity, the chemical's reaction to nitrates in the stomach from processed meats, and the potential for drug contamination at the manufacturing sources in China and elsewhere.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.